" Research and Hope for Interstitial Lung Disease in Scleroderma"
Erica L Herzog, MD

Fall Research Forum, HSS, NYC
November 2013

About Dr. Herzog:

 

Dr. Herzog received her Bachelor’s and MD degree from the University of North Carolina at Chapel Hill. After residency in Internal Medicine at Mount Sinai Medical Center in New York City, NY, Dr. Herzog came to Yale to pursue fellowship in Pulmonary and Critical Care Medicine. During this time she also obtained her PhD in Investigative Medicine from Yale’s graduate school of arts and sciences. Upon her graduation in 2005 Dr. Herzog joined faculty in the department of Internal Medicine in 2006, first as an instructor and then as assistant professor. Dr. Herzog’s laboratory focuses on the relationship between chronic inflammation, neuronal guidance proteins, and lung fibrosis in a variety of fibrosing lung diseases including IPF, scleroderma and sarcoidosis. The Herzog Lab is part of Yale University School of Medicine. In addition to research, Dr. Herzog is a practicing physician at Yale New Haven Hospital and the Winchester Chest Clinic, New Haven, CT. She has published numerous articles in conjunction with doctors who are in the forefront of finding treatments directed toward improving the quality of life for those with scleroderma and toward the ultimate discovery of a cure for the disease.

The information presented on this site is intended for educational purposes only. Neither the featured speakers, nor the Scleroderma Foundation, nor Starlight Productions (the producers of these videos) suggest, recommend or endorse any specific treatment for any individual. Patients are advised consult their own health care providers for treatment options.